Single arm clinical trial to evaluate the efficacy of oral administration of Chitrakadi Kwatha in the management of Prathama-Dwitiya Patalagata Timira with reference to myopia.

SANE GURUJI AROGYA KENDRA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1) Patient Enrolled with symptoms of Prathama-Dwitiya Patalagata Timira i.e.
•Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient
•nature of blurriness), Dooramnekshate (difficulty of distant vision) in Shalakya OPD.
•2) Age-18 to 40 years.
•3) Patient who have <-3D refractive index in the eyes.
•4) Patient of either gender.
•5) Patient having visual acuity of 6/12, 6/18, 6/24, 6/36, 6/60, or less than 6/60 in the
•6) Patient who ready to give consent.

•1) Patient who have symptoms of Tritiya and Chaturtha Patalagata Timira will be
•2) Congenital type of myopia, pathological type of myopia, acquired or secondary type of
•myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced,
•post keratitis. etc. will be excluded.
•3) Myopia associated with other ocular diseases like cataract, glaucoma, etc.
•4) Patient who have myopia associated with other refractive errors such as astigmatism,
•presbyopia.
•5) Patient who have known case of hypertension, diabetes mellitus, Rheumatic arthritis
•or any other arthritic conditions, rheumatic heart disease, thyroid disorder, asthma,
•Kochâ??s, HIV will be excluded.
•6) Patient who have active infectious diseases i.e. viral, fungal, bacterial conjunctivitis,
•trachoma, blepharitis.
•7) Patient below 18 years and above 40 years will be excluded.

发起方